Effect of Rituximab on Expanded Disability Status Scale and Relapse Rate in Multiple Sclerosis Patients
Crossref DOI link: https://doi.org/10.1007/s12031-020-01523-w
Published Online: 2020-03-06
Published Print: 2020-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mazdeh, Mehrdokht
Khamseh, Mohammad
Taheri, Mohammad
Ghafouri-Fard, Soudeh
Text and Data Mining valid from 2020-03-06
Version of Record valid from 2020-03-06
Article History
Received: 6 February 2020
Accepted: 28 February 2020
First Online: 6 March 2020